About InSightec

Excellence Backed by Experience
InSightec® is the pioneer and global leader in MR guided focused ultrasound technology for image guided acoustic surgery.

ExAblate® 2000 system was the first system to use the MR guided focused ultrasound technology. The ExAblate 2000 system received CE mark in 2002 and the Food and Drug Administration (FDA) approval in 2004 for the treatment of symptomatic uterine fibroids. ExAblate 2000 received the European CE Mark for pain palliation of bone metastases in June 2007 and for adenomyosis in June 2010. This device has won numerous innovation awards and has been used to treat thousands
of patients around the world.

ExAblate® OR is a non-invasive Operating Room. The system incorporates interchangeable cradles for each application that are interfaced with the common table. ExAblate OR offers both commercially approved and research treatment options for a multitude of clinical indications such as: uterine fibroids and adenomyosis**, breast cancer, prostate cancer, pain palliation of bone metastases
and various other indications*.

ExAblate® One is designed to address women’s health needs, including the treatment of uterine fibroids, adenomyosis**, and clinical research of breast cancer.*

ExAblate® Neuro** is designed for the non-invasive treatment of various brain disorders.

* All of these applications have or will require a full FDA Investigation Device Exemption for clinical trials in the United States. Not all applications are approved in all regions.
Please consult your local representatives and read the product labeling specific for your region to determine approved indications for use.

** Requires FDA investigational device exemption.

History
InSightec was founded in 1999 when GE Healthcare (then GE Medical Systems) and Elbit Medical Imaging transferred their proprietary technology to the company to enable it to concentrate on developing the promising MR guided focused ultrasound surgery both companies had investigated. Since then, InSightec has invested over $100 million in research and development. The company holds over 30 patents with additional intellectual property pending.

Team
The 160 InSightec staff includes world class scientists and engineers with extensive experience in the wide variety of disciplines involved with this enhanced technology and teamed with leading application specialists, manufacturing, service and other personnel. The company is headquartered in Tirat Carmel, Israel, near the port city of Haifa. Its US offices are in Dallas, Texas.

Clinical Partners
InSightec has established clinical collaborations with leading hospitals and medical research institutions around the world. Many of these sites participate in sponsored trials to gather clinical data that will advance the company’s technology and create an ever-widening spectrum of clinical applications. InSightec has over 85 sites globally.

Shareholders
InSightec Ltd. is a privately held company founded in 1999 and owned by Elbit Imaging, Elbit Medical Technologies, General Electric, MediTech Advisors, LLC and employees. InSightec is headquartered in Haifa, Israel with US offices in Dallas, 

For more information please contact us.